JP2009523156A5 - - Google Patents

Download PDF

Info

Publication number
JP2009523156A5
JP2009523156A5 JP2008549886A JP2008549886A JP2009523156A5 JP 2009523156 A5 JP2009523156 A5 JP 2009523156A5 JP 2008549886 A JP2008549886 A JP 2008549886A JP 2008549886 A JP2008549886 A JP 2008549886A JP 2009523156 A5 JP2009523156 A5 JP 2009523156A5
Authority
JP
Japan
Prior art keywords
compound
alkyl
use according
unbranched
saturated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008549886A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009523156A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/050363 external-priority patent/WO2007080194A2/en
Publication of JP2009523156A publication Critical patent/JP2009523156A/ja
Publication of JP2009523156A5 publication Critical patent/JP2009523156A5/ja
Pending legal-status Critical Current

Links

JP2008549886A 2006-01-13 2007-01-15 癌の処置のためのγ線照射と組み合わせた化合物の使用 Pending JP2009523156A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75908806P 2006-01-13 2006-01-13
US60/759,088 2006-01-13
PCT/EP2007/050363 WO2007080194A2 (en) 2006-01-13 2007-01-15 Use of tpp ii inhibitors in combination with gamma-irradiation for the treatment of cancer

Publications (2)

Publication Number Publication Date
JP2009523156A JP2009523156A (ja) 2009-06-18
JP2009523156A5 true JP2009523156A5 (https=) 2010-02-25

Family

ID=36609604

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008549886A Pending JP2009523156A (ja) 2006-01-13 2007-01-15 癌の処置のためのγ線照射と組み合わせた化合物の使用
JP2008549887A Pending JP2009523157A (ja) 2006-01-13 2007-01-15 虚血および神経変性の処置のための化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008549887A Pending JP2009523157A (ja) 2006-01-13 2007-01-15 虚血および神経変性の処置のための化合物

Country Status (8)

Country Link
US (2) US20100168038A1 (https=)
EP (2) EP1971357A2 (https=)
JP (2) JP2009523156A (https=)
KR (1) KR20080085035A (https=)
CN (1) CN101370509A (https=)
AU (1) AU2007204314A1 (https=)
CA (1) CA2636533A1 (https=)
WO (2) WO2007080194A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009000297A1 (en) * 2007-06-25 2008-12-31 Oncoreg Ab Tpp ii inhibitors for use in combination with chemotherapy for the treatment of cancer
EP2170364A2 (en) * 2007-06-25 2010-04-07 Oncoreg AB Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
US8779002B2 (en) * 2007-10-15 2014-07-15 Salk Institute For Biological Studies Methods for treating a variety of diseases and conditions, and compounds useful therefor
MX2012006877A (es) 2009-12-18 2012-08-31 Idenix Pharmaceuticals Inc Inhibidores de virus de hepatitis c de arileno o heteroarileno 5, 5 - fusionado.
WO2011159685A2 (en) * 2010-06-16 2011-12-22 The Regents Of The University Of Michigan Inhibition of wdr5 interaction with its binding partners and therapeutic methods
AU2011348220B2 (en) * 2010-12-22 2017-09-07 The Salk Institute For Biological Studies Cyclic CRF antagonist peptides
DK3049428T3 (en) 2013-09-23 2019-03-04 Dr August Wolff Gmbh & Co Kg Arzneimittel ANTI-INFLAMMATORY TRIPEPTIDES
EP3171941B1 (en) * 2014-07-24 2021-03-24 Naurex Inc. N-methyl-d-aspartate receptor modulators and methods of making and using same
CN111603560A (zh) * 2020-06-22 2020-09-01 泉州台商投资区秋鑫茶业有限公司 茶叶γ-氨基丁酸在肿瘤放射治疗上的应用
BR112023018676A2 (pt) 2021-03-18 2023-10-10 Seagen Inc Conjugado anticorpo-fármaco, composição farmacêutica, métodos de tratamento de uma doença ou condição e de um câncer, e, composição de conjugado ligante-fármaco

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC2306A1 (fr) * 1990-08-22 1993-09-27 Syntello Vaccine Dev Kb Peptides bloquant les infections par le virus de l'immunodeficience humaine et methode de leur utilisation
US5627035A (en) * 1990-08-22 1997-05-06 Syntello Vaccine Development Ab Peptides that block human immunodeficiency virus and methods of use thereof
US6335360B1 (en) * 1997-12-23 2002-01-01 Institut National De La Sante Et De La Recherche Medicale (Inserm) Tripeptidyl peptidase inhibitors
US6258932B1 (en) * 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
DE10105039A1 (de) * 2001-02-05 2002-08-08 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
WO2003024995A1 (en) * 2001-09-19 2003-03-27 Tripep Ab Molecules that block viral infectivity and methods of use thereof
US20040097422A1 (en) * 2002-06-14 2004-05-20 Karl Munger Methods of use for tripeptidyl peptidase II inhibitors as anticancer agents
EP1716247A1 (en) * 2004-01-31 2006-11-02 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with tripeptidyl-peptidase 2 (tpp2)

Similar Documents

Publication Publication Date Title
JP2009523156A5 (https=)
JP7248247B2 (ja) Ｗｔ１抗原ペプチドコンジュゲートワクチン
JP6207509B2 (ja) 固形腫瘍を治療するためのｆａｐ活性化プロテアソーム阻害剤
US11965015B2 (en) IL-7R-α-γ binding compounds
JP6651546B2 (ja) カッパ（κ）オピオイド受容体（ＫＯＲ）アゴニストとしての新規の短鎖ペプチド
US20230331801A1 (en) Il-2r-beta-gamma binding compounds
US11248030B2 (en) Dual IL-2R and IL-7R binding compounds
CN112533937A (zh) 用于结合cd38的肽配体
KR100225679B1 (ko) 노나펩티드 봄베신 길항제
JP3350701B2 (ja) ボンベシン類似体類
JP2008506709A5 (https=)
CN103415530A (zh) 新型的含有非肽性交联结构的交联肽、以及该交联肽的合成方法和用于该方法的新型有机化合物
JP7292366B2 (ja) ドラプロイン‐ドライソロイインペプチド誘導体
JP6671956B2 (ja) Ｅｒａｐ１によるトリミング機能をきっかけとしたコンジュゲートワクチン
JPWO2018181648A1 (ja) Ｗｔ１癌抗原ペプチドおよびこれを含むペプチドコンジュゲート体
US20220119492A1 (en) Il-2r-beta-gamma binding compounds and uses thereof
JP7209963B2 (ja) Ｗｔ１ヘルパーペプチド及びこれと癌抗原ペプチドコンジュゲート体との組合せ
NZ246815A (en) Phenylalanine analogs of bombesin and compositions thereof
CN102282163A (zh) 肿瘤坏死因子-α抑制肽及其应用
CN1030703C (zh) 神经激肽a的拮抗剂的制备方法
HUT55798A (en) Process for producing peptide derivatives and pharmaceutical compositions comprising same as active ingredient
JPH04253997A (ja) ペプチド類
TW202417032A (zh) 環肽或其鹽及ｍｄｍｘ抑制劑
TW200838558A (en) New immunomodulating oligopeptides
CA2182486C (en) Cyclic neurokinin a antagonists